Thursday, July 19, 2018 2:51:12 AM
https://www.marsdd.com/wp-content/uploads/2012/09/Pathway-to-Commercialization-for-an-In-Vitro-Diagnostic-in-the-US.pdf
I think Arrayit's test(s) are considered Class 1 (low risk) LDT (lab developed test) so approvals shouldn't take as long as the higher risk tests (Class 2 and 3).
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM